Geode Capital Management’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,492,903
| Closed | -$149K | – | 4519 |
|
|
2025
Q4 | $149K | Buy |
1,492,903
+214,747
| +17% | +$136K | ﹤0.01% | 3999 |
|
|
2025
Q3 | $773K | Buy |
1,278,156
+309,615
| +32% | +$146K | ﹤0.01% | 3478 |
|
|
2025
Q2 | $301K | Sell |
968,541
-1,182,851
| -55% | -$458K | ﹤0.01% | 3730 |
|
|
2025
Q1 | $1.05M | Buy |
2,151,392
+67,250
| +3% | +$39.6K | ﹤0.01% | 3292 |
|
|
2024
Q4 | $1.78M | Sell |
2,084,142
-7,527
| -0.4% | -$47.2K | ﹤0.01% | 3172 |
|
|
2024
Q3 | $17.8M | Sell |
2,091,669
-7,146
| -0.3% | -$42.1K | ﹤0.01% | 2039 |
|
|
2024
Q2 | $9.8M | Buy |
2,098,815
+1,494,387
| +247% | +$7.07M | ﹤0.01% | 2336 |
|
|
2024
Q1 | $4.11M | Buy |
604,428
+26,757
| +5% | +$120K | ﹤0.01% | 2801 |
|
|
2023
Q4 | $1.94M | Buy |
577,671
+134,199
| +30% | +$334K | ﹤0.01% | 3111 |
|
|
2023
Q3 | $1.1M | Buy |
443,472
+2,967
| +0.7% | +$4.89K | ﹤0.01% | 3279 |
|
|
2023
Q2 | $564K | Buy |
440,505
+79,427
| +22% | +$105K | ﹤0.01% | 3595 |
|
|
2023
Q1 | $293K | Hold |
361,078
| – | – | ﹤0.01% | 3870 |
|
|
2022
Q4 | $274K | Buy |
361,078
+29,012
| +9% | +$22.9K | ﹤0.01% | 3932 |
|
|
2022
Q3 | $308K | Buy |
332,066
+169,623
| +104% | +$203K | ﹤0.01% | 3970 |
|
|
2022
Q2 | $154K | Sell |
162,443
-125,487
| -44% | -$205K | ﹤0.01% | 4403 |
|
|
2022
Q1 | $607K | Sell |
287,930
-15,313
| -5% | -$41K | ﹤0.01% | 3845 |
|
|
2021
Q4 | $2.71M | Sell |
303,243
-12,851
| -4% | -$169K | ﹤0.01% | 3220 |
|
|
2021
Q3 | $5.25M | Buy |
316,094
+25,174
| +9% | +$435K | ﹤0.01% | 2886 |
|
|
2021
Q2 | $6.04M | Buy |
290,920
+34,953
| +14% | +$662K | ﹤0.01% | 2785 |
|
|
2021
Q1 | $4.8M | Buy |
255,967
+66,479
| +35% | +$1.43M | ﹤0.01% | 2807 |
|
|
2020
Q4 | $4.17M | Buy |
189,488
+19,660
| +12% | +$409K | ﹤0.01% | 2697 |
|
|
2020
Q3 | $3.52M | Buy |
169,828
+3,908
| +2% | +$102K | ﹤0.01% | 2585 |
|
|
2020
Q2 | $6M | Buy |
165,920
+39,224
| +31% | +$1.64M | ﹤0.01% | 2225 |
|
|
2020
Q1 | $4.14M | Buy |
126,696
+58,946
| +87% | +$2.38M | ﹤0.01% | 2247 |
|
|
2019
Q4 | $1.85M | Buy |
67,750
+43,634
| +181% | +$748K | ﹤0.01% | 3040 |
|
|
2019
Q3 | $265K | Buy |
+24,116
| New | +$228K | ﹤0.01% | 3681 |
|
Geode Capital Management's APLT Position: Q1 2026 in Review
Geode Capital Management sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 1,492,903 shares — an estimated $149K sold.
Geode Capital Management first reported a position in APLT in Q3 2019 and held it in 26 quarters. The position peaked at $17.8M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Geode Capital Management reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Geode Capital Management sold 1,492,903 Applied Therapeutics shares in Q1 2026, an estimated $149K.
- Geode Capital Management first reported a position in Applied Therapeutics in Q3 2019 and held it in 26 quarters.
- Geode Capital Management's Applied Therapeutics position peaked at $17.8M in Q3 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.